NCT04952857View on ClinicalTrials.gov

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

December 10, 2021

Conditions
Covid19
Interventions
DRUG

cholecalciferol 6 lakh IU

vitamin D levels and serum calcium will be assessed at day 3,7, 14.

Trial Locations (1)

160012

Deptt of Endocrinology, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT04952857 - Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease | Biotech Hunter | Biotech Hunter